Kirkland & Ellis
Kiyong Song
- Deals
- 3
- Latest
- Jul 2026
- Most deals in
- Biotech
Firm
- Kirkland & Ellis Law firm · 2026 · 3 deals
Often works with
- Shellie Freedman 2 deals together
- Dean Shulman 2 deals together
- Liam Murphy 2 deals together
- Matthew Goulding 1 deal together
- Matthew Dunnet 1 deal together
- Michelle Kilkenney 1 deal together
- Sumner Fontaine 1 deal together
- Roger Lucas 1 deal together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Jul 2026 | Asembia | – | Peak Rock Capital | Acquisition | Legal adviser to Peak Rock Capital (acquirer) | Completed | – | Pharma Services+2 | Peak Rock Capital acquisition of Asembia |
| Apr 2026 | Kelonia Therapeutics | – | Eli Lilly and Company | Acquisition | Legal adviser to Eli Lilly and Company (acquirer) | Announced | 7,000.0 | Biotech+2 | Eli Lilly and Company acquisition of Kelonia Therapeutics |
| Mar 2026 | Transcend Therapeutics | – | Otsuka | Acquisition | Legal adviser to Transcend Therapeutics (target) | Announced | 700.0 | Biotech+2 | Otsuka acquisition of Transcend Therapeutics |
Deals where Kiyong Song is named on the firm's deal team, by the firm or the press.